Local Institution
Port Elizabeth, Eastern Cape 6045
0 studies enrolling now · 16 studies all time
What they study most
Acute Coronary Syndrome, Bipolar Disorder, Breast Cancer, Cancer, HIV, HIV Infection, HIV Infections, HIV, Pediatric, Head and Neck Cancer, Melanoma, Metastases, Non-small Cell Lung Cancer (NSCLC)
Studies at this site
- Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck — Completed
- Effects of Abatacept in Patients With Early Rheumatoid Arthritis — Completed
- Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer — Completed
- Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone — Completed
- Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes — Completed
- Phase IIIB Study Evaluating the Effects of Atazanavir Powder With Ritonavir in HIV-infected Pediatric Patients — Completed
- Safety Sudy of Atazanavir Boosted With Ritonavir in the Treatment of HIV Infection in Pediatric Patients — Completed
- Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access — Completed
- Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC) — Completed
- Phase III Acute Coronary Syndrome — Stopped early
- Study to Characterize the Pharmacokinetics of a Single Dose of SC Abatacept 125 mg Using the BD Autoinjector or the Prefilled Syringe — Completed
- Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer — Stopped early
- Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma — Completed
- Study of Aripiprazole in Patients With Bipolar I Disorder — Completed
- BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada — Completed
- Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected Subjects — Completed